Companies · ACRS · Pharmaceutical Preparations

Aclaris Therapeutics, Inc. (ACRS)

Every material event, decoded in plain English — what each one means for the stock.

ATI-052 advances toward quarterly dosing as cash runway extends through 2028

ATM capacity refreshed, preserving funding flexibility but adding dilution risk

Open live on AllSight — the whole market, decoded →